Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-25 @ 2:42 AM
Ignite Modification Date:
2025-12-26 @ 1:22 AM
NCT ID:
NCT01802333
Group ID:
EG002
Title:
Arm III (Vorinostat, High-dose Cytarabine, Idarubicin)
Description:
INDUCTION/RE-INDUCTION: Patients receive vorinostat PO TID on days 1-3, high-dose cytarabine IV continuously on days 4-7, and idarubicin IV over 15 minutes on days 4-6. Patients with residual blasts may receive re-induction treatment beginning on day 28. Patients achieving CR or CRi may proceed to allogeneic HSCT or to consolidation therapy.
Deaths Number Affected:
103
Deaths Number At Risk:
None
Serious Number Affected:
75
Serious Number At Risk:
211
Other Number Affected:
206
Other Number At Risk:
211
Study:
NCT01802333
Results Section:
NCT01802333
Adverse Events Module:
NCT01802333